Modern Technologies for Preclinical and Clinical Optimisation
In the past decades, the translation of preclinial and clinical trials of drug development from 2D to 3D platforms and the development of diverse in vitro disease models have been well elaborated in an enormous number of reviews. This new report provides an overview of the various 3D culture models that are used in drug development. The current report version reviewed the advantages of 3D models compared to 2D cell cultures, the limitations, and the fields of application of these models and their techniques of production. It delivers advanced market profiling, interactive mindmaps, information about companies and investors, technology application use cases and other actionable information.
As a result, this release includes insigths about 165 companies that develop organoids, organ-on-a-chip technologies, lab automation tools and mpre than 250 of their investors.